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The coronavirus mouse hepatitis virus strain A59 (MHV-A59) encodes a 3C-like proteinase (3CLpro) that is proposed to be
responsible for the majority of the processing events that take place within the replicase polyproteins pp1a and pp1ab. In
this study we demonstrate that the Q9392S940 peptide bond, located between the polymerase and Zn-finger regions of
pp1ab (the POL2Zn site), is processed by the 3CLpro, albeit inefficiently. Mutagenesis of the POL2Zn site, as well as the
previously identified HD123C site in the 1a region of pp1a and pp1ab, demonstrated that the amino acid residues at the P2
and P1 positions of the cleavage site, occupied by L and Q, respectively, were important determinants of 3CLpro substrate
specificity. Finally, a direct comparison of the 3CLpro-mediated cleavages at the HD123C and POL2Zn sites was made by
determining the rate constants using synthetic peptides. The results show that while a larger polypeptide substrate carrying
the HD123C site was processed more efficiently than a polypeptide substrate carrying the POL2Zn site, cleavage of the
synthetic peptide substrates containing these two cleavage sites occurred at similar efficiencies. This indicates that the
overall conformation of a large polyprotein substrate is important in the accessibility of the cleavage site to the proteinase.
© 1999 Academic Press
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aINTRODUCTION
The family Coronaviridae is composed of a group of
iruses that cause a variety of diseases in different
nimal hosts. The murine coronavirus, mouse hepatitis
irus (MHV), causes a range of diseases in mouse,
ncluding enteritis, hepatitis, encephalitis, and a demy-
linating disease (Holmes and Lai, 1996; Houtman and
leming, 1996; Lai, 1990). Coronaviruses, along with the
rteriviruses, are classified under the newly established
rder Nidovirales based on the similarities in their ge-
ome organization and replication strategy (Cavanagh,
997; de Vries et al., 1997). The name Nidovirales origi-
ates from the Latin word nidus, meaning “nest,” and
efers to the 39 nested set of subgenomic mRNAs that is
roduced during viral infection (de Vries et al., 1997). As
ith all positive-strand RNA viruses, entry of the viral
enome into the cytoplasm is followed by the translation
f the positive-strand RNA genome, resulting in the ex-
ression of viral proteins. The coronavirus genome is
rganized into seven genes that are separated by stop
odons and intergenic sequences (Holmes and Lai,
996; Lai, 1990). Thus, translation of the viral genome
esults only in the expression of gene 1 proteins. The rest
f the viral genome is expressed through subgenomic
1 To whom correspondence and reprint requests should be ad-
ressed at 203A Johnson Pavilion, 3610 Hamilton Walk, Philadelphia,
A 19104-6076. Fax: (215) 573 4858. E-mail: weisssr@mail.med.Lpenn.edu.
471RNAs that are transcribed by the viral RNA-dependent
NA polymerase encoded in gene 1. Replication of the
iral genome also requires the replicase proteins en-
oded in gene 1. Thus, for both viral replication and
ubgenomic mRNA transcription to take place, the ex-
ression of gene 1 products is essential.
The replicase gene (gene 1) (Fig. 1) of coronaviruses,
panning 20–22 kb, is organized into two overlapping
pen reading frames, ORF1a and ORF1b (Bonilla et al.,
994; Lee et al., 1991). The expression of the downstream
RF1b is mediated by a ribosomal frameshift event that
s aided by the formation of a pseudoknot structure
ithin the overlapping region (Bredenbeek et al., 1990;
rierley et al., 1987; Herold and Siddell, 1993). Thus, two
olypeptides, pp1a and pp1ab, are expressed from gene
, with the translation of pp1ab being only 25–40% as
fficient as that of pp1a in in vitro studies (Bredenbeek et
l., 1990; Brierley et al., 1987). Through a series of intri-
ate cotranslational and posttranslational processing
vents, these polyproteins are converted into a func-
ional complex that in turn is responsible for both
enomic RNA replication and subgenomic mRNA tran-
cription (de Vries et al., 1997). Responsible for these
rocessing events are at least two or three viral protein-
ses encoded within the ORF1a region of gene 1 (Fig. 1).
wo of these proteinase domains, by sequence analysis,
hare similarities with the cellular proteinase papain. A
hird proteinase, resembling the poliovirus 3C protein-
se, has also been identified (Gorbalenya et al., 1989;
ee et al., 1991). The coronavirus 3C-like proteinase
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
(
m
t
p
r
a
1
3
t
e
3
p
i
p
p
3
(
k
v
d
i
(
a
E
3
t
t
t
c
c
a
t
i
C
r
a
n
m
F
h
s
1
L
e
e
i
1
H
d
p
(
R
n
1 ).
472 PIN˜O´N, TENG, AND WEISS3CLpro), flanked on either side by hydrophobic, possibly
embrane-spanning regions (HD1 and HD2), is believed
o be the prinicipal viral proteinase responsible for the
rocessing events leading to the formation of the viral
eplicase complex, with as many as 11 potential cleav-
ge sites identified throughout pp1ab (Gorbalenya et al.,
989; Lee et al., 1991) (see Fig. 1). The presence of the
CLpro is conserved in all coronavirus genomes studied
o date (Bonilla et al., 1994; Boursnell et al., 1987; Eleouet
t al., 1995; Herold et al., 1993; Lee et al., 1991). The
CLpro of MHV-A59 has been identified as a 29-kDa
rotein (p29) both in in vitro study and in MHV-A59-
nfected cells (Pin˜o´n et al., 1997). (Lu et al. (1995) re-
orted a molecular weight of 27 kDa for the same
olypeptide.) The catalytic residues of the MHV-A59
CLpro, His3374, and Cys3478 have also been identified
Lu et al., 1995). Treatment of infected cells with E-64d, a
nown inhibitor of the 3CLpro, results in the inhibition of
iral RNA replication in these cells (Kim et al., 1995),
emonstrating the importance of the action of the 3CLpro
n the events leading to viral replication. Van Dinten et al.
1999) demonstrated the importance of 3CLpro cleav-
ges using an infectious clone of the related arterivirus
AV; introduction of mutations into the candidate ORF 1b
CLpro cleavage sites had drastic effects on RNA syn-
FIG. 1. Map of ORF1a and 1b showing the locations of the predicted f
PLP-1 and PLP-2), X domain (X), poliovirus 3C-like proteinase (3CLp
NA-dependent RNA polymerase (POL), zinc-finger domain (Zn), and
umbers and the cleavage site sequences from the P5 to the P59 pos
994; Bredenbeek et al., 1990; Gorbalenya et al., 1989; Lee et al., 1991hesis and virus replication. These fndings indicate that ohis proteinase is a good potential target for antiviral
herapy.
The cleavage sites of the coronavirus 3CLpro (Fig. 1)
onform to the consensus XQ2Z (arrow indicates site of
leavage), with X being a hydrophobic residue, usually L,
lthough the amino acids I, M, V, and F are also found in
his position (de Vries et al., 1997). At the P19 position, Z
s usually a small uncharged residue such as S, A, G, or
(de Vries et al., 1997), with S being the most common
esidue at this position. Data recently obtained for the
vian infectious bronchitis virus (IBV), the human coro-
avirus (HCV-229E), and MHV-A59 demonstrated that
any of these predicted cleavage sites are functional.
or all three strains, many of the cleavage sites in pp1a
ave been identified, including a noncanonical LQ2N
ite that had not previously been predicted (Lu et al.,
995; 1998; Liu and Brown, 1995; Liu et al., 1997; Ng and
iu, 1998; Pin˜o´n et al., 1997; Tibbles et al., 1996; Ziebuhr
t al., 1995; Ziebuhr and Siddell, 1999). In addition, sev-
ral of the processing sites in ORF1b have also been
dentified in both IBV and HCV-229E (Gro¨tzinger et al.,
996; Heusipp et al., 1997a,b; Liu et al., 1994, 1998).
owever, for MHV, there has been greater difficulty in
emonstrating processing by the 3CLpro at any of the
redicted ORF1b cleavage sites. In this study we dem-
al domains. The following domains are shown: papain-like proteinase
rophobic domains (HD1 and HD2), growth factor-like domain (GFL),
se (HEL). The predicted 3CLpro cleavage sites are indicated by the
e listed in table form (arrow indicates site of cleavage) (Bonilla et al.,unction
ro), hyd
helica
ition arnstrate processing by the 3CLpro at the putative ORF1b
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473MHV 3CLpro: CLEAVAGE SITE SEQUENCE REQUIREMENTSleavage site situated between the putative polymerase
POL) and zinc finger (Zn) domains (the POL2Zn site)
Fig. 2). Furthermore, identification of this site allowed us
o make comparisons between the efficiencies of pro-
essing at this ORF1b site and a previously identified site
n ORF1a located at the junction between hydrophobic
omain 1 (HD1) and the 3CLpro (the HD123C site).
RESULTS
dentification of a 3CLpro cleavage site in ORF1b
We have previously demonstrated processing at an
RF1a site in MHV-A59, located at the junction between
D1 and the 3CLpro (HD123C), by a recombinant MHV-
59 3CLpro expressed as a fusion protein with the mal-
ose binding protein (MBP) (Pin˜o´n et al., 1997). The plas-
id pET21-NX.3C C3478A, encoding the carboxy-termi-
al 98 amino acids of HD1 and the inactivated 3CLpro, is
n vitro transcribed and translated to yield a 40-kDa
ubstrate NX.3C (Fig. 3A, lane 1). As previously demon-
trated (Pin˜o´n et al., 1997), upon addition of the recom-
inant MBP-3CLpro, this substrate is efficiently pro-
FIG. 2. Functional domains of MHV-A59 gene 1 and diagram of plasm
b. (B) Enlarged map of the HD1.3C.HD2 region and schematic represen
rom S3334 and Q3636 (Bonilla et al., 1994; Bredenbeek et al., 1990; Le
re shown. pET 21-HA-HD1.3C encodes MHV-A59 amino acids from S
nder the control of the T7 promoter (ê). pET21-NX.3C encodes MHV-A
cid sequences from S3334 to G3636 fused to the mal E gene encodin
verexpression of the 3CLpro in Escherichia coli. (C) Enlarged map of P
rom this region. The position of the Q9392S940 cleavage site at the jun
mino acids from L714 to Q1201 under the control of the T7 promoter.essed into the 29-kDa proteinase (3C) and the 11-kDa aD1-derived product (NX) (lane 2). Other studies using
imilar methods have led to the identification of ORF1a
leavage sites downstream of the 3CLpro, including a
reviously unidentified, noncanonical LQ2N site (Lu et
l., 1998). However, the demonstration of processing at
RF1b sites has proven to be difficult. Our work with
apain-like proteinase 1 (PLP-1) showed that substrate
ength, and possibly substrate conformation, played an
mportant role in the ability of a substrate to be cleaved
fficiently by the proteinase (Teng et al., 1999). We there-
ore created several substrates of various lengths, en-
oding different putative cleavage sites in ORF1b, in
rder to investigate processing by the recombinant MBP-
CLpro. Of these, only the substrate expressed from
ET21-POL.Zn, encoding MHV-A59 ORF1b amino acids
714–Q1201, proved to be useful in our investigations. In
itro transcription–translation of the construct pET21-
OL.Zn resulted in the expression of a 55-kDa full-length
ubstrate, POL.Zn (predicted molecular weight 56 kDa)
Fig. 3B, lane 1). Upon incubation of this substrate with
he recombinant MBP-3CLpro enzyme, cleavage be-
ween Q939 and S940, would give rise to two products,
structs. (A) Location of the predicted functional domains in ORF1a and
of plasmids derived from this region. The 3CLpro lies within the region
., 1991). The positions of the catalytic residues, His3374 and Cys3478,
G3636 directly downstream of the influenza hemagglutinin (HA) tag
ino acids from K3258 to Q3636. pMal-3C.wt encodes MHV-A59 amino
altose-binding protein (MBP). The construct pMAL-3C is used for the
Zn region of ORF1b and schematic representation of plasmids derived
tween POL and Zn is shown. pET21-POL.Zn encodes MHV-A59 ORF1bid con
tation
e et al
3149 to
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474 PIN˜O´N, TENG, AND WEISSf 26 kDa (POL) and a C-terminal product with a pre-
icted molecular weight of 30 kDa (Zn). In Fig. 3B, lane 2,
he addition of the recombinant MBP-3CLpro to the
OL.Zn substrate resulted in the production of a 26-kDa
rotein which presumably corresponds to the N-terminal
rocessing product. Mutagenesis of Q939 to K (lane 4) or
(lane 6) abolished this processing, suggesting that the
leavage is occurring at the predicted site and that, in
iew of the substrate specificity demonstrated, the ob-
erved processing event is in fact due to the action of the
ecombinant MBP-3CLpro.
We were unable to detect the C-terminal 30-kDa prod-
ct by SDS–PAGE analysis. One explanation could be
hat p30 cannot be resolved from p26 in our gel system.
There have been previous reports of viral proteins mi-
rating with electrophoretic mobilities different from that
xpected. The MHV-A59 3CLpro (p29) itself migrates
ith an electrophoretic mobility faster than its predicted
olecular weight of 33 kDa (Pin˜o´n et al., 1997; Lu et al.,
FIG. 3. Demonstration of trans processing by the recombinant MB
ranscribed, and translated substrate from pET21-NX.3C was incubated
lane 1) and the processed products were separated on a 15% SDS–
igration of the 29-kDa 3CLpro- and the 11-kDa HD1-derived cleav
ET21-POL.Zn was in vitro transcribed and translated. Radiolabeled s
olumn buffer/20% glycerol (denoted by plus or minus signs above the
he electrophoretic migration of p26 is indicated by an arrow on the
arkers is indicated on the left of each panel.995)). In addition, the predicted cleavage product p30 2as approximately half the methionine content of p26,
hich may contribute to the difficulty in its detection.
haracterization of 3CLpro cleavage sites
The identification of these two cleavage sites, one in
RF1a (HD123C) and one in ORF1b (POL2Zn), allowed
s to further define the amino acids required for efficient
rocessing by the 3CLpro. For these experiments, we
hose to use the pET21-HA.HD1.3C construct, rather
han other plasmids encoding 3CLpro, because the
A.HD1.3C polypeptide can be efficiently cleaved both in
is and in trans and does not require membranes for its
leavage (Pin˜o´n et al., 1997).
Several sets of mutations, from the P3 to the P39
osition, were introduced into the construct pET21-
A.HD1.3C by PCR mutagenesis using the mutagenesis
rimers outlined in Table 1. The effect of these cleavage
ite mutations on the autocatalytic cis release of the
ro. (A) trans processing at the HD123C site. Radiolabeled, in vitro
BP-3CLpro (lane 2) or an equal volume of column buffer/20% glycerol
el. The arrows on the right of the panel indicate the electrophoretic
oducts (NX). (B) trans processing at the POL2Zn site. The plasmid
e was incubated either with MBP-3CLpro or with an equal volume of
, respectively). Processed products were analyzed on a 12% SDS gel.
the panel. The molecular weight in kilodaltons of prestained proteinP-3CLp
with M
PAGE g
age pr
ubstrat
lanes
right of9-kDa 3CLpro was assayed by the expression of the
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475MHV 3CLpro: CLEAVAGE SITE SEQUENCE REQUIREMENTSutated substrates using in vitro transcription–transla-
ion, followed by SDS–PAGE analyses of the protein
roducts (Fig. 4). We observed that the L3332 and Q3333
esidues, at the P2 and P1 positions, respectively, were
ost sensitive to mutations. Any mutation at either one of
hese positions inhibited the autocatalytic cis processing
y the 3CLpro (Fig. 4, lanes 6–10). In contrast, mutations
t any of the other positions studied were tolerated and
he expression of precursor proteins harboring muta-
ions at these sites still resulted in the autocatalytic
T
Primers for PCR Amp
Primer name Nucleotide s
ORF1a
FMP F3331A CTCTGTTACTACATCA
RMP F3331A TATACCAGACTGTAAA
FMP F3331H CTCTGTTACTACATCA
RMP F3331H TATACCAGACTGTAAA
FMP F3331W TCTGTTACTACATCAT
RMP F3331W CTATACCAGACTGTAA
FMP L3332I GTTACTACATCATTTA
RMP L3332I CACTATACCAGACTGT
FMP L3332S GTTACTACATCATTTT
RMP L3332S CACTATACCAGACTGT
FMP Q3333A TACTACATCATTTTTA
RMP Q3333A CTTCACTATACCAGAC
FMP Q3333K ACTACATCATTTTTAA
RMP Q3333K CTTCACTATACCAGAT
FMP Q3333R ACTACATCATTTTTAC
RMP Q3333R CTTCACTATACCAGAC
FMP S3334A ACATCATTTTTACAGG
RMP S3334A CATCTTCACTATACCT
FMP S3334C ACATCATTTTTACAGT
RMP S3334C CATCTTCACTATACCA
FMP G3335A TCATTTTTACAGTCTG
RMP G3335A CACCATCTTCACTATA
FMP G3335P ATCATTTTTACAGTCT
RMP G3335P CACCATCTTCACTATA
FMP I3336L ATTTTTACAGTCTGGT
RMP I3336L CGACACCATCTTCACT
ORF1b
FMP V937S TATTTAAGAAGTGCAT
RMP V937S CCAACGCTTTGCAGCG
FMP L938I GAAGTGCAGTGATCCA
RMP L938I CCAACGCTTTGGATCA
FMP L938M GAAGTGCAGTGATGCA
RMP L938M CAACGCTTTGCATCAC
FMP Q939K GAAGTGCAGTGCTGAA
RMP Q939K GGCACCAACGCTTTTC
FMP Q939R GAAGTGCAGTGCTGCG
RMP Q939R CAGGCACCAACGCTTC
FMP S940A GTGCAGTGCTGCAAGC
RMP S940A CGCAGGCACCAACGGC
FMP S940N GCAGTGCTGCAAAACG
RMP S940N GCAGGCACCAACGTTT
a Mutated codons are in boldface.
b Reverse position of MHV-A59 gene 1 indicates negative-strand prielease of the 29-kDa 3CLpro. Exceptions are the i3334C substitution at position P19 (lane 12) and the
3335P substitution at position P29 (lane 14). These
utations also abolish the cis processing by the 3CLpro.
he effect of the G3335P mutation, however, is expected
ince the introduction of a P at this site could result in a
rastic change in the conformation at the cleavage site.
To investigate whether the cleavage sequence re-
uirements for trans cleavage at the HD123C site by the
ecombinant MBP-3CLpro parallel that observed for cis
leavage, the same set of cleavage site mutations were
n and Mutagenesis
e (59–39)a MHV-A59 gene 1b
ACAGTCTGGTATA 10184–10217
TGTAGTAACAGAG 10217–10184
ACAGTCTGGTATA 10184–10217
TGTAGTAACAGAG 10217–10184
CAGTCTGGTATAG 10185–10218
ATGTAGTTACAGA 10218–10185
TCTGGTATAGTG 10188–10220
TGATGTAGTAAC 10220–10188
TCTGGTATAGTG 10188–10220
TGATGTAGTAAC 10220–10188
TGGTATAGTGAAG 10190–10223
AAATGATGTAGTA 10223–10190
GGTATAGTGAAG 10191–10223
AAATGATGTAGT 10223–10191
GGTATAGTGAAG 10191–10223
AAATGATGTAGT 10223–10191
ATAGTGAAGATG 10194–10226
TAAAAATGATGT 10226–10194
ATAGTGAAGATG 10194–10226
TAAAAATGATGT 10226–10194
GTGAAGATGGTG 10197–10229
CTGTAAAAATGA 10229–10197
AGTGAAGATGGTG 10196–10229
CTGTAAAAATGAT 10229–10196
GAAGATGGTGTCG 10199–10232
AGACTGTAAAAAT 10232–10199
CAAAGCGTTGG 16331–16362
CTTCTTAAATA 16362–16331
TTGG 16338–16362
CTTC 16362–16338
TTG 16338–16361
TTC 16361–16338
TTGGTGCC 16338–16366
TGCACTTC 16366–16338
TTGGTGCCTG 16338–16368
ACTGCACTTC 16368–16338
GTGCCTGCG 16341–16370
GCACTGCAC 16370–16341
GCCTGC 16343–16369
CACTGC 16369–16343ABLE 1
lificatio
equenc
GCTTT
GCTGA
CATTT
TGTGA
GGTTA
CCATG
TACAG
ATAAA
CACAG
GAAAA
GCGTC
GCTAA
AATCT
TTTAA
GGTCT
CGTAA
CAGGT
GCCTG
GTGGT
CACTG
CTATA
GCAGA
CCTAT
GGAGA
CTAGT
AGACC
CGCTG
ATGCA
AAGCG
CTGCA
AAGCG
TGCAC
AAGCG
AGCAC
AAGCG
GCAGC
CGTTG
TTGCA
TTGGT
TGCAG
mer.ntroduced into the construct pET21-HA.HD1.3C C3478A,
w
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476 PIN˜O´N, TENG, AND WEISShich also carries an inactivating mutation in the cata-
ytic cysteine residue of the proteinase. The release of
he 29-kDa 3CLpro from this precursor can only be
ccomplished by incubation with the recombinant
BP-3CLpro. Figure 5 showed that the effect of
hese mutations on trans cleavage paralleled the
ffects on cis cleavage. Those mutations centering
round the P2 and P1 positions of the cleavage site
L3332 and Q3333, respectively) affected trans process-
ng the most.
For the POL2Zn cleavage site in ORF1b, similar mu-
agenesis studies were conducted in order to determine
he cleavage specificity requirements at this site (Fig. 6).
utations from the P3 to the P19 position were intro-
uced into the plasmid pET21-POL.Zn. The mutant sub-
trates were expressed using an in vitro transcription–
ranslation system and then incubated with the recom-
inant MBP-3CLpro. The effect of the mutations on the
FIG. 4. HD123C cleavage site mutagenesis: cis processing at the H
arboring mutations at the HD123C cleavage site in the plasmid pE
ildtype and mutant plasmids, followed by separation of precursor and
y an arrow to the right of the panel. Molecular weight markers are inroduction of p26 was assayed by SDS–PAGE and com- 3ared to the processing of the wildtype POL.Zn substrate
Fig. 6, lanes 1 and 2). The results were similar to that
bserved with the ORF1a HD123C site in that the L938
nd Q939 residues, at the P2 and P1 positions respec-
ively, were most sensitive to mutations. The L938I mu-
ation (Fig. 6, lanes 5 and 6) resulted in the inhibition of
26 processing, indicating the sensitivity of this site to a
onservative change. However, the L938M substitution
Fig. 6, lanes 7 and 8) did not abolish processing of p26.
utation of Q939 to either K (lanes 9 and 10) or R (lanes
1 and 12) abolished processing at this site. Substitution
f S940 with an A (lanes 13 and 14) was tolerated,
hereas mutating S940 to the bulkier N (lanes 15 and 16)
esulted in the inhibition of p26 processing.
The results of mutagenesis studies on both the
D123C and POL2Zn cleavage sites demonstrate that
he P1 and P2 positions at the cleavage site are the
rimary determinants of cleavage specificity by the
site. The autocatalytic release of the 29-kDa 3CLpro from precursors
.HD1.3C was assayed by in vitro transcription and translation of the
ts on a 12% SDS gel. The electrophoretic migration of p29 is indicated
on the left.D123C
T21-HA
producCLpro in both cis and trans processing.
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477MHV 3CLpro: CLEAVAGE SITE SEQUENCE REQUIREMENTSomparison of ORF1a and ORF1b sites
We investigated the efficiency of processing at the
RF1a site compared to the ORF1b site. The substrates,
X.3C and POL.Zn, were incubated with a fixed amount
f recombinant proteinase for increasing periods of time.
e observed that the ORF1a substrate, NX.3C, is readily
rocessed within 1 h, with the substrate completely con-
erted into product by 20 h (Fig. 7A). Processing of the
RF1b substrate, however, is not observed until after 4 h
f incubation with the recombinant proteinase. Further-
ore, cleavage of POL.Zn occurs at a much lower level
nd does not reach completion even after 30 h (Fig. 7B).
his inefficiency of processing of the POL2Zn site com-
ared to the HD123C site may be explained in two ways.
irst, although the primary sequences of the two sites
eveal no obvious reason why one is processed more
fficiently than the other, it is possible that the subtle
ifferences in the sequences of the two sites are enough
o make the HD123C site a more efficient substrate than
he POL2Zn site. Alternatively, the difference may not be
nherent to the primary sequence of the cleavage sites,
FIG. 5. HD123C cleavage site mutagenesis: trans processing at th
rocessing were introduced into pET21-HA.HD1.3C C3478A, which a
quivalent counts per minute of radiolabeled substrates expressed fr
quivalent volume of column buffer/20% glycerol (1/2 MBP-3CLpro). Cl
igration of p29 is indicated by an arrow on the right. Molecular weigut rather to the conformation of the entire substrate as swhole. It is possible that the substrate conformation of
X.3C allows the recombinant proteinase better access
o the cleavage site. In the POL.Zn substrate, the cleav-
ge site may be more obscured, and in this manner the
irus regulates both when and how much of its encoded
roteins are produced.
To determine whether the difference in processing
fficiencies at the HD123C and POL2Zn sites can be
ttributed to the primary sequences of the cleavage
ites, we synthesized a 14-mer peptide, representing the
6–P89 residues of the HD123C cleavage site, and a
5-mer peptide, representing the P6–P99 amino acids of
he POL2Zn cleavage site. Each peptide was then incu-
ated with the recombinant MBP-3CLpro and the result-
ng cleavage products were separated from each other
nd from the substrate by reverse-phase chromatogra-
hy. For the ORF1a peptide, reverse-phase chromatog-
aphy of the reaction at zero time resulted in a single
eak, representing the peptide substrate, in the elution
rofile (Fig. 8A). Incubation with MBP-3CLpro followed by
hromatography resulted in two additional peaks, repre-
23C site. The same cleavage site mutants used in the study of cis
bors a mutation at the catalytic cysteine residue of the proteinase.
se mutant plasmids by TnT were incubated with MBP-3CLpro or an
products were then separated on a 10% SDS–gel. The electrophoretic
kers are indicated on the left.e HD1
lso har
om the
eavage
ht marenting the cleavage products, and a reduction in the
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478 PIN˜O´N, TENG, AND WEISSubstrate peak. Microsequencing of the cleavage prod-
cts confirmed that cleavage had occurred between
3333 and S3334.
For the ORF1b peptide similar results were observed
n that the peptide substrate eluted as a single peak at
ero time (Fig. 8B). Incubation with MBP-3CLpro prior to
eparation resulted in two new peaks, representing the
wo cleavage products. A reduction in the substrate peak
as also observed. Again, the authenticity of cleavage of
he synthetic peptide was confirmed by microsequenc-
ng of the cleavage products, which showed that cleav-
ge had occurred between Q939 and S940.
The level of cleavage of the ORF1a peptide was not
ny different from, and in some cases was less than, that
f the ORF1b peptide. We observed that under identical
eaction conditions no more than 30% of the ORF1a
eptide was cleaved by the MBP-3CLpro, whereas with
he ORF1b peptide the level of cleavage was between 30
nd 50%.
In order to allow direct comparison between the cleav-
ge efficiencies of the NX23C and POL2Zn sites, we
etermined the k cat and K m values for the reactions with
he synthetic peptides described above. Results show
hat cleavage of the ORF1a peptide by the recombinant
21
FIG. 6. POL2Zn cleavage site mutagenesis. Recombinant MBP-3CL
ubstrates generated from pET21-POL.Zn that encoded a wildtype cle
olumes containing equivalent counts per minute were incubated with
f column buffer/20% glycerol (denoted by a minus sign above the lane
f the panel. Molecular weight markers are indicated on the left.BP-3CLpro yielded a k cat of 0.015 s , and a K m of p.32 6 0.50 mM. With the ORF1b peptide the k cat was
lightly slower, with a value of 0.006 s21, and the K m was
alculated at 0.27 6 0.07 mM.
Our results therefore show that cleavage (k cat) of the
RF1a peptide occurred at only a slightly higher rate
2.5-fold) than that of the ORF1b peptide. The lack of
ubstantial difference between the k cat values is not
urprising given that the sequences of the peptides are
ery similar. Interestingly, when the catalytic efficiency
k cat/K m) was taken into consideration, the ORF1b pep-
ide (k cat/K m 5 2.1 3 10
25 M21s21) was a slightly better
ubstrate than the ORF1a peptide (k cat/K m 5 6.4 3 10
26
21s21). Taken together, the peptide cleavage results
resented here suggest that the cleavage efficiencies of
he two peptides are similar.
DISCUSSION
The action of viral-encoded proteinases is essential to
iral replication (Dougherty and Semler, 1993). This
akes viral-encoded proteinases potentially good tar-
ets for antiviral drugs. In the murine coronavirus, two
uch proteinases are under continued investigation in
rder to better understand the manner in which these
s used in posttranslational trans cleavage assays with radiolabeled
sequence or harbored mutations around the POL2Zn site. Substrate
Lpro (denoted by plus sign above the lanes) or an equivalent volume
electrophoretic migration of p26 is indicated by the arrow to the rightpro wa
avage
MBP-3C
s). Theroteinases function. Papain-like proteinase 1 (PLP-1)
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479MHV 3CLpro: CLEAVAGE SITE SEQUENCE REQUIREMENTSas been linked to the processing of several nonstruc-
ural proteins encoded in the 59 end of the viral genome
Baker et al., 1989; Bonilla et al., 1995; Denison et al.,
992; 1995; Hughes et al., 1995). These cleavage prod-
cts, p28 and p65, are not yet linked with any known viral
unction. However, those viral proteins with presumed
unctions in viral replication and viral RNA transcription,
uch as the RNA-dependent RNA polymerase (POL) and
he zinc-finger/helicase (Zn-HEL) proteins, are believed
o be processed by the 3C-like proteinase of the virus.
he 3CLpro is predicted to cleave at, at least, 11 sites in
p1ab. Many of the cleavage sites located in the 1a
egion of pp1ab have been shown to be functional cleav-
ge sites and processing by the 3CLpro at these sites
as been demonstrated in the coronaviruses IBV (Liu et
l., 1997; Liu and Brown, 1995; Ng and Liu, 1998; Tibbles
t al., 1996), HCV-229E (Ziebuhr et al., 1995; Ziebuhr and
iddell, 1999), and MHV-A59 (Lu et al., 1995, 1998; Pin˜o´n
t al., 1997). Some of the mature viral products resulting
rom these cleavages have also been identified in in-
ected cells (Liu et al., 1997; Lu et al., 1998; Ng and Liu,
998; Pin˜o´n et al., 1997; Ziebuhr and Siddell, 1999; Deni-
on et al., 1999). According to computer predictions,
urther processing at the Q9392S940, Q15392C1540,
20602S2061, and Q24342A2435 sites located in the 1b
egion of MHV-A59 pp1ab would result in mature viral
roducts of 106, 67, 59, 42, and 33 kDa, respectively,
FIG. 7. Cleavage efficiencies at the HD123C and POL2Zn sites. Su
X.3C (A) or POL.Zn (B) were incubated with MBP-3CLpro for increasin
oint specified above each lane by the addition of 23 SDS–sample bu
f A and B, respectively. Molecular weight protein markers are shownorresponding to POL, Zn-HEL, and the three C-terminal- eost cleavage products. In HCV-229E, viral products of
05, 71, and 41 kDa, corresponding to the POL, Zn-HEL,
nd the second C-terminal-most proteins, have been
dentified in infected cells and the role of the 3CLpro in
he processing of these products has been authenticated
n vitro (Gro¨tzinger et al., 1996; Heusipp et al., 1997a,b).
imilarly, in the case of IBV, viral proteins of 100, 39, and
5 kDa have been identified in infected cells (corre-
ponding to POL and the two C-terminal-most proteins)
nd cotransfection experiments have implicated the
CLpro in the processing of these viral products (Liu et
l., 1994, 1998). For MHV-A59, however, demonstration of
rocessing at any MHV cleavage site in the 1b region of
p1ab has lagged behind that of HCV and IBV. Here we
eport the first demonstration of processing at the site
etween POL and Zn in pp1ab by the MHV-A59 3CLpro.
The cleavage at the POL2Zn site is highly inefficient
ompared to the processing observed at the HD123C
ite, as evidenced by the time course assays illustrated
n Fig. 7. Phosphorimager analyses indicate that the
OL.Zn substrate is cleaved fivefold less efficiently than
he NX.3C substrate (data not shown). The differences in
hese efficiencies, however, could not be explained by
he subtle differences in the primary sequences of the
leavage sites alone. In fact, when presented to the
nzyme in the context of a 14- or 15-mer peptide sub-
trate, there was no substantial difference in cleavage
volumes containing equivalent counts per minute of either substrate
ds of time. The trans processing reaction was terminated at the time
e electrophoretic migration of p29 and p26 are indicated to the right
left of A.bstrate
g perio
ffer. Thfficiency between these two peptides, an observation
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480 PIN˜O´N, TENG, AND WEISShat would seem to contradict the results obtained with
he larger polyprotein substrates. Recently, Ziebuhr and
iddell (1999) investigated the efficiency of processing at
everal HCV-229E 3CLpro sites located at the C-termi-
us of pp1a or the central region of pp1ab. They ob-
erved that several viral products were produced less
fficiently than others, with reduced cleavage activity at
wo ORF 1a sites, between V-Q35462S3547 and
-Q38242N3825, compared with cleavage at the sites
lanking the 3Clpro domain. The corresponding LQ2N
FIG. 8. Chromatograms of cleavage products of the synthetic pep-
ides corresponding to ORF1a amino acids and ORF1b amino acids. A
nd B show chromatograms of ORF1a peptide (1 mM) and ORF1b
eptide (1 mM), respectively, at 0 h and after 16 h of incubation with
BP-3CLpro (17.5 mM enzyme) at 30°C. In both panels the chromato-
rams for t 5 0 h are offset to allow comparison between the two time
oints. The asterisks (*) indicate the cleavage products that were used
n peptide sequencing in order to confirm the sites of cleavage.ite in MHV-A59 has also been shown to be less effi- 2iently cleaved than the LQ2S sites flanking the 3CLpro
omain (Lu et al., 1998). In the case of L-Q38242N3825
n HCV-229E, additional peptide cleavage data demon-
trated that the properties of the cleavage sequence
tself, rather than the overall conformation of the polypep-
ide and the accessibility of the cleavage site, contribute
o the observed inefficiency of processing at this site
Ziebuhr and Siddell, 1999). While our results do not
ontradict theirs, they do demonstrate that, in vivo, the
onformation of a larger polypeptide substrate is likely to
e as important a determinant of cleavage as is the
rimary structure and sequence of the cleavage site. Our
esults clearly show that, at least with the case of the
OL2Zn site of MHV-A59, the observed inefficiency of
leavage was likely due to the overall conformation of
he polypeptide, which may directly translate into the
ccessibility of the cleavage site, rather than the primary
equence of the site. Taken together, both sets of results
ighlight important regulatory mechanisms employed by
he virus to coordinate the temporal production and the
ccumulation of the various replicase proteins.
Thus, the very slow in vitro processing at the ORF 1b
leavage site, compared with that at the ORF 1a site,
enerally correlates with the levels of ORF 1a and ORF
b polypeptides found in infected cells. However, there
re inherent differences between in vitro cleavage reac-
ions with either recombinant proteins or peptide sub-
trates and in vivo processing; these include the lengths
f the substrates, the concentration of the enzyme and
ubstrates, as well as the subcellular localization of
eplication complexes in vivo (Denison et al., 1999;
iebuhr and Siddell, 1999). These differences may all
ontribute to the extended lengths of time necessary for
n vitro cleavages.
The substrate specificity of the coronavirus 3CLpro
as been determined mainly through the identification of
unctional cleavage sites and a visual inspection of these
leavage site sequences. Mutagenesis has been done
rimarily to verify the authenticity of the cleavage site
nd most mutagenesis studies have not extended be-
ond the Q residue that is absolutely conserved at the P1
osition in all 3CLpro cleavage sites identified to date.
e have extended our mutagenesis studies to cover the
3 to P39 positions of the cleavage site sequence. Our
esults demonstrated that the substrate sequence spec-
ficity of the 3CLpro is primarily influenced by the amino
cid residues present at the P2 and P1 positions of the
leavage site. Substitution of the Q residue at the P1
osition with any other amino acid has resulted in sub-
trates that could not be cleaved by the 3CLpro, demon-
trating the importance of this residue in the substrate.
e could not detect any processing in substrates con-
aining mutations at this position (Figs. 4–6). The P2
osition of the cleavage site is most often occupied by an
; however, in some cleavage sites identified in HCV-
29E, this position is occupied by a V or an I (Gro¨tzinger
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481MHV 3CLpro: CLEAVAGE SITE SEQUENCE REQUIREMENTSt al., 1996; Ziebuhr and Siddell, 1999), suggesting that
his position is not as strictly conserved as the P1 posi-
ion and may thus be able to tolerate some mutations.
owever, our results demonstrated otherwise, in that
ven a conservative change to I resulted in a reduction of
leavage (Figs. 4–6), to below 20%, as measured by
hosphorimager analysis (data not shown). This sug-
ests that perhaps an I at the P2 position of the cleavage
ite can be functional only when compensated for else-
here in the substrate sequence. The only change tol-
rated at this position was a change to M in the P2
osition at the POL2Zn site (Fig. 6). Interestingly, the
HM strain of MHV encodes an M instead of an L at this
osition (Lee et al., 1991). Thus such a mutation resulted
n a wildtype JHM POL2Zn site and a cleavage efficiency
quivalent to wildtype levels. This provides indirect evi-
ence that the POL2Zn site in JHM is a functional
CLpro site. Although the S found at the P19 position of
oth the HD123C and POL2Zn sites is not as sensitive
o mutations, we observed that some mutations, such as
3334C (in the HD123C site) (Fig. 4) and S940N (in the
OL2Zn site) (Fig. 6), are not tolerated. Additionally, both
3334A and S940A substitutions, though tolerated, re-
ulted in a reduction, but not complete inhibition of cleav-
ge (Figs. 4–6), suggesting that the residue at the P19
osition also plays a role in substrate recognition, al-
hough to a lesser extent than those at the P1 and P2
ositions.
Aside from the amino acid residues at the P2, P1, and
19 positions, the amino acid sequences surrounding the
cissile Q2S(A,G) peptide bonds that are recognized by
he 3CLpro do not share any other significant primary
tructure similarity. Furthermore, the presence of an LQA
ripeptide not cleaved by the proteinase (Lu et al., 1998)
ould again suggest the existence of a common confor-
ational determinant shared by all 3CLpro susbstrates
hat is necessary for 3CLpro-mediated processing.
The POL2Zn site is the first functional cleavage site
dentified in the ORF1b region of the MHV-A59 pp1ab.
urther work remains to be done in order to identify other
unctional cleavage sites in ORF1b. Additionally, the ma-
ure viral products resulting from these processing
vents remain to be identified in infected cells. A direct
omparison of the cleavage efficiencies of each site will
elp to elucidate the complex posttranslational process-
ng pattern of the MHV-A59 gene 1 polyprotein, as well
s provide insight into the regulatory mechanisms em-
loyed by the virus to maintain the production of its
roteins under control.
MATERIALS AND METHODS
lasmids
The parental plasmids used in this study are illus-
rated in Fig. 2. The plasmids pET21-NX.3C, pET21-A.HD1.3C, and pMAL-3C.wt have all been described wlsewhere (Pin˜o´n et al., 1997). pET21-NX.3C encom-
asses MHV-A59 nucleotides 9912–10661, encoding the
ast 98 amino acids of HD1 and the entire 303-amino-
cid region encompassing the 3CLpro (from K3235 to
3636). pET21-NX.3C C3478A is the same as pET21-
X.3C but carries the inactivating C3478A mutation in
he catalytic cysteine residues of the proteinase. The
lasmid pET21-HA.HD1.3C encodes MHV-A59 nucleo-
ides 9654–10661, encoding HD1 and the 3CLpro from
3149 to Q3636, directly behind the influenza hemagglu-
inin (HA) epitope under the control of the T7 promoter in
ET21a. The plasmid pET21-HA.HD1.3C C3478A con-
ains the 3CLpro inactivating mutation C3478A in the
ackground of the parental pET21-HA.HD1.3C plasmid.
he plasmid pMAL-3C.wt encodes MHV-A59 nucleotides
0209–10661, corresponding to the 3CLpro region from
3334 to Q3636, behind the mal E gene in the pMALc2
ector (New England Biolabs). This plasmid encodes the
CLpro domain fused to the coding sequence of the
altose binding protein and is used for overexpression
f the recombinant MBP-3CLpro enzyme.
A region of MHV-A59 gene 1, from nucleotides 15677
o 17140, corresponding to ORF1b amino acids L714 to
1201, was PCR amplified from a plasmid encoding the
ntire ORF1b sequence using the primers F1bP 2383–
394 (59-TTCGAATTCCCCGGGGGATCCCTTATGGCATG-
AATGGACAC-39) and R1bP 3846–3835 (59-CGAATTC-
TCTAGAAAGCTTGCTGAAACGTCTCAGGCACACT-39).
he resulting PCR fragment was digested with BamHI
nd HindIII (denoted by the underlined sequences in the
rimers) and cloned into the corresponding sites of
ET21a, resulting in the plasmid pET21-POL.Zn.
ite-directed mutagenesis
The pET21-HA.HD1.3C cleavage site mutants L3332I,
3332S, Q3333K, Q3333R, and S3334A were created by
wo rounds of PCR as described previously (Bonilla et al.,
995; Hughes et al., 1995) using the FMP and RMP
rimers listed in Table 1 and the primers FIJ31 (59-TG-
CTTGTCATGTATGGTGC-39) and RSP 10661–10644 (59-
ACATATCCTACAGAACC-39). The resulting mutant frag-
ents were digested with KpnI and BamHI and cloned
nto the same sites in pET21-HA.HD1.3C. All other cleav-
ge site mutants in pET21-HA.HD1.3C were created us-
ng the QuikChange mutagenesis kit (Stratagene) follow-
ng the manufacturer’s protocols. The mutagenic primers
sed are listed in Table 1. Following PCR amplification,
he amplified plasmids were digested with the restriction
nzyme DpnI, which digests methylated and hemimeth-
lated DNA, thus destroying the parental plasmid and
ny hybrids containing one parental strand and one
utated strand. Escherichia coli XL1-Blue supercompe-
ent cells (Stratagene) were then transformed with the
utated plasmids. The presence of the desired mutation
as verified by sequencing. The fragments containing
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482 PIN˜O´N, TENG, AND WEISShe HD1.3C cleavage site mutations were also subcloned
nto pET21-HA.HD1.3C C3478A using the NdeI and
amHI sites in order to create plasmids carrying both the
nactivating C3478A mutation and mutations at the cleav-
ge site. These plasmids were used to express sub-
trates used in trans cleavage assays.
All pET21-POL.Zn cleavage site mutants V937S, L938I,
938M, Q939K, Q939R, S940A, and S940N were created
sing the QuikChange mutagenesis kit as described
bove. The primers used in creating these mutants are
lso listed in Table 1.
n vitro transcription and translation
Cell-free expression of plasmid DNAs was carried out
sing the TnT rabbit reticulocyte lysate-coupled tran-
cription–translation system (Promega) at 30°C for 2 h,
s previously described (Pin˜o´n et al., 1997). The incor-
oration of [35S]methionine into acid precipitable counts
as used as an indicator of protein synthesis. Equivalent
mounts of acid precipitable counts were directly ana-
yzed by SDS–polyacrylamide gel electrophoresis (SDS–
AGE) or used in posttranslational proteolytic assays as
ndicated. Radioimmunoprecipitations were carried out
s described previously (Bonilla et al., 1995; Denison et
l., 1991).
verexpression and partial purification
f the recombinant 3CLpro
Expression of the recombinant 3CLpro from pMAL-
C.wt (NEB), which expresses 3CLpro as an MBP-3CL
usion protein, and the purification of the fusion protein
as carried out according to the manufacturer’s protocol
nd as described by Herold et al. (1996). Briefly, E. coli
B1 cells transformed with pMAL-3C.wt were grown at
7°C in the presence of ampicillin (100 mg/ml) until the
600nm reached 0.8, at which point the cells were induced
ith isopropylthio-b-D-galactoside at a final concentra-
ion of 0.5 mM for 4 h at 25°. Cells were harvested and
hen resuspended in 10 ml of column buffer [20 mM
ris–Cl (pH 7.5)], 200 mM NaCl, 1 mM EDTA, 1 mM DTT]
er gram of cells. The cell suspension was then lysed by
onication. Cell debris was pelleted by centrifugation at
000g for 30 min. The crude lysates were diluted 1:5 in
olumn buffer and then loaded onto an amylose column
bed volume 6 ml), preequilibrated with column buffer, at
flow rate of 1 ml/min. The column was then washed
ith 12 column volumes of column buffer and the MBP-
CLpro fusion protein was eluted with column buffer
ontaining 10 mM maltose. Fractions of 1 ml were col-
ected and those containing the 72-kDa recombinant
BP-3CLpro were identified by analyzing 10-ml aliquots
y SDS–PAGE. Fractions containing the recombinant
roteinase were pooled and the concentration of the
usion proteinase was determined using the Bradford
ssay against known concentrations of bovine serum ulbumin. The recombinant proteinase was stored at
80°C in column buffer supplemented with 20% glyc-
rol.
osttranslational proteolytic assays
Radiolabeled substrates containing the cleavage se-
uences of HD1.3C or POL.Zn (Fig. 2) were generated
sing the TnT rabbit reticulocyte lysate system. Lysate
olumes containing equivalent counts per minute were
ncubated with approximately 1–10 mg of recombinant
roteinase or an equivalent volume of column buffer/20%
lycerol at 30°C for 12–16 h or, where applicable, the
pecified lengths of time. The processed products were
nalyzed by SDS–PAGE followed by autoradiography.
hosphorimager analysis was carried out as previously
escribed (Hughes et al., 1995; Teng et al., 1999).
eptide assays
Recombinant MBP-3CLpro enzyme (1.27 mg/ml in elu-
ion buffer supplemented with 20% glycerol and 2 mM
TT, 17.5 mM enzyme) was incubated with synthetic
eptide ORF1a (0.02 to 0.6 mM in 10% DMSO), with the
equence H2N-Thr–Thr–Ser–Phe–Leu-Gln2Ser–Gly–Ile–
al–Lys–Met–Val–Ser-COOH, corresponding to ORF1a
mino acids 3328 to 3341 (arrow indicates cleavage site)
r ORF1b peptide (0.02 to 0.25 mM in 10% DMSO), with
he sequence H2N-Arg-Ser-Ala-Val-Leu-Gln2Ser-Val-Gly-
la-Cys-Val-Val-Cys-Ser-COOH, corresponding to ORF1b
mino acids 934 to 948 (arrow indicates cleavage site) in
final reaction volume of 100 ml. The reactions were
llowed to proceed at 30°C for 60–120 min, at which time
he reactions were quenched by addition of trichloroace-
ic acid (TCA) to 1% final concentration. The samples
ere then chilled on ice, and the denatured protein was
recipitated by centrifugation. For zero time point sam-
les, the enzyme was mixed with TCA prior to the addi-
ion of peptide substrates and the reactions were carried
ut as described above.
Separation of cleavage product from substrate was
arried out with the A¨KTApurifier System (Amersham
harmacia Biotech) equipped with a Sephasil Peptide
18 5-mm ST 4.6/100 reverse-phase column (Amersham
harmacia Biotech). Elution was performed with a linear
radient of 92% eluent A (0.1% aqueous TFA)/8% eluent B
0.1% TFA in 90% acetonitrile/10% water) up to 100%
luent B (Seybert et al., 1997) over 26 min (flow rate 0.8
l/min, detection at 215 nm). With the ORF1a peptide the
evel of cleavage was no more than 30%, whereas with
he ORF1b peptide the level of cleavage was between 30
nd 50%.
The data obtained were fitted to the Michaelis–Men-
en equation and the k cat and K m values were obtained
sing Kaleidagraph 3.08 (Synergy Software).
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